Vaxart, Inc short interest in 2022
In 2022, Vaxart, Inc's disclosed short interest ran from 17.78% of shares outstanding on 14 Jan 2022 to 17.34% on 30 Dec 2022, a change of -0.44 percentage points. The year's high was 20.17% on 30 Sep 2022 and its low 17.34% on 30 Dec 2022, averaging 18.44% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.71 days on 14 Apr 2022. Full history: Vaxart, Inc.
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025
2022 in figures
- Start of year
- 17.78% (14 Jan 2022)
- End of year
- 17.34% (30 Dec 2022)
- Change
- -0.44 pp
- High
- 20.17% (30 Sep 2022)
- Low
- 17.34% (30 Dec 2022)
- Average
- 18.44%
- Highest days to cover
- 11.71 (14 Apr 2022)
- SEC filings marked
- 8
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 17.78% | 8.22 | |
| 31 Jan 2022 | 18.08% | 7.57 | |
| 15 Feb 2022 | 18.79% | 10.81 | |
| 28 Feb 2022 | 19.04% | 9.88 | 10-K filed, results (8-K) |
| 15 Mar 2022 | 18.57% | 9.91 | |
| 31 Mar 2022 | 17.70% | 8.70 | |
| 14 Apr 2022 | 18.05% | 11.71 | |
| 29 Apr 2022 | 18.60% | 9.37 | |
| 13 May 2022 | 18.38% | 6.41 | 10-Q filed, results (8-K) |
| 31 May 2022 | 18.00% | 8.12 | |
| 15 Jun 2022 | 18.37% | 9.16 | |
| 30 Jun 2022 | 17.86% | 7.11 | |
| 15 Jul 2022 | 17.50% | 10.17 | |
| 29 Jul 2022 | 18.87% | 9.54 | |
| 15 Aug 2022 | 18.34% | 8.18 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 18.28% | 10.85 | |
| 15 Sep 2022 | 18.97% | 8.32 | |
| 30 Sep 2022 | 20.17% | 7.82 | |
| 14 Oct 2022 | 19.37% | 7.71 | |
| 31 Oct 2022 | 19.00% | 8.83 | |
| 15 Nov 2022 | 18.77% | 6.04 | results (8-K), 10-Q filed |
| 30 Nov 2022 | 18.62% | 9.81 | |
| 15 Dec 2022 | 18.06% | 6.25 | |
| 30 Dec 2022 | 17.34% | 4.06 |
See also: Vaxart, Inc's full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.